Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Background<p>Muscle wasting and sarcopenia in advanced breast cancer correlates with poor outcomes. The serum creatinine-to-cystatin C ratio (CCR) is a potential muscle mass biomarker, but its prognostic value in advanced breast cancer is unclear.</p>Methods<p>This multicenter retr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Huijie Deng (5664421) (author)
Daljnji autori: Jiacheng Yang (4867897) (author), Guanyu Zheng (602277) (author), Biyao Zhang (3160059) (author), Yuzhou Wang (600730) (author), Yuye Wu (22381971) (author), Shufen Mo (21743543) (author), Shengchao Huang (22686392) (author), Yuanqi Zhang (18483375) (author), Lixia Li (407712) (author)
Izdano: 2025
Teme:
Clinical and Sports Nutrition
breast cancer
creatinine
cystatin C
creatinine–cystatin C
muscle mass
sarcopenia
mortality
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
Budi prvi tko komentira!
Najprije se prijavi

Slični predmeti